Introduction
At the time of the 2000 Census, foreign-born individuals accounted for 11.1% of the total U.S. population. 1 By 2009, this percentage increased to 12% totaling 36.7 million foreign-born individuals in the U.S. 2 The U.S. foreign-born population includes immigrants (legal permanent residents), humanitarian migrants (e.g., refugees), temporary migrants (e.g., students), and unauthorized migrants (undocumented individuals residing in the U.S.). Persons born abroad to American parents or born in Puerto Rico or other U.S. Island Areas are not considered foreign-born. 1 Refugees constitute a special subset of the foreign-born population, resettle in some regions more often than others, and the states with the largest number of resettled refugees are Florida, California, Texas, New York, and Minnesota. 3 There is substantial evidence that many of the vaccine-preventable outbreaks in the U.S. have been directly related to disease importation. In 2008, close to 90% of the measles cases in the US were either acquired overseas or imported cases, leading to 7 outbreaks and 135 infected persons. 4 Even though rubella disease is less severe than measles, congenital rubella syndrome can be devastating and life-threatening. Fortunately, only two cases were reported in 4 the U.S. in 2009. 5 However, in one of the two cases, the individual was travelling throughout her first trimester in India and China. For these reasons, Congress has mandated vaccinations for immigrant populations in the US to decrease the public health burden from imported vaccine-preventable diseases.
As a whole, foreign-born individuals have unique immunization-related needs that can be influenced by country of origin, age of arrival to the U.S., and circumstances surrounding their migration (e.g., refugees/asylees, adoptees).
Primary care physicians must be aware of these needs and be comfortable providing the appropriate services to this population.
Start with the basics
In the primary care setting, foreign-born patients may present with complicated medical and social histories, and it is important to keep in mind the standard age-appropriate preventive care recommendations that apply to all patients. Compared to their U.S. cohorts, foreign-born individuals may have more difficulty accessing healthcare due to cultural and linguistic barriers. 6, 7 Foreign-born patients may be more likely to access healthcare for acute care rather than for health maintenance, so sick visits should be viewed as an opportunity to provide these important services, including vaccination. Many of these patients will not return for a separate health maintenance visit, even if the recommendation is made. In many developing countries, the concept of a health maintenance visit is largely unknown, so the idea of returning to simply 5 discuss wellness issues may be viewed with skepticism, even if patients outwardly voice agreement with the follow-up plan. Vaccination should not be delayed due to mild respiratory tract infections or other acute illness, although vaccination should be deferred for moderate or severe illness. 8 Assessing Risk: Important Vaccine-Preventable Diseases for Foreign-Born
Populations
Knowing a patient's country of origin can help to assess the patient's level of risk for certain preventable diseases. Unfortunately, for the sake of examining the incidence of disease in these populations, immigrants are usually grouped together as a single unit, even though the incidence and prevalence of diseases differs among particular subgroups. In addition, it is also important for the primary care physician to have a general understanding of the cultural norms in these individuals, to better assess an individual's risk for disease (i.e. the risk of sexually-transmitted infections in populations with a high prevalence of sexual abuse).
Despite near total eradication of numerous vaccine-preventable diseases in the U.S., the rest of the world has not been as fortunate. In 2002, WHO (World Health Organization) estimated that 14% (1.4 million deaths) of the total global mortality in children under the age of 5 years old was due to disease that could have been prevented with routine vaccination. The 6 distribution of these deaths is seen in Figure 1 . 9 In the following sections we will focus specifically on tuberculosis, viral hepatitis, and human papillomavirus. These conditions were selected for special emphasis due to the greater burden of disease caused by these infections among immigrant populations.
Infectious Disease Burden: TUBERCULOSIS
Tuberculosis (TB) is very common in much of the world, with the continent of Africa having the largest number of high-prevalence nations. Continents with lowest rates of tuberculosis include North America, Europe, and Australia.
According to the World Health Organization, the country with the highest incidence for the combined years of 2007-2008 was Swaziland in southern Africa, with an incidence of 510 per 100,000 population (compared to 2 per 100,000 in the U.S.). 10 Although immunization against TB is not commonly performed (and not routinely recommended) in the U.S., 11 there are many parts of the world where for years children have been routinely given the BCG (Bacille Calmette-Guérin) vaccine to prevent TB. While the vaccine has not been shown to make a large epidemiologic impact on TB infection per se, it seems to confer some protection against serious TB disease among children, and may also protect against the development of leprosy. 12 Prior vaccination with BCG can sometimes result in false positive results for the standard tuberculin skin test (TST). 13 Since many 7 foreign-born individuals come from areas with endemic TB, further testing is necessary to identify these high-risk individuals.
Two newer blood tests serve as alternatives to the TST and are unaffected by prior BCG vaccination: the ELISA-based QuantiFERON-TB Gold, which measures interferon gamma concentration in supernatant, and the enzymelinked immunospot (ELISpot; T-SPOT TB), which enumerates interferon-gammasecreting T cells. Both tests have better specificity than the TST, although the immunospot test appears to have higher sensitivity for detecting latent tuberculosis infection. 13 Despite decreases in active TB cases for US-born individuals, the numbers of active TB cases among foreign-born individuals in the US is still relatively elevated and have remained stable over the years ( Figures   2,3 ). Identification and treatment of these individuals is necessary to decrease the burden of tuberculosis disease. Unfortunately, simple, inexpensive point-ofcare tests with this level of sensitivity and specificity are still not available. 14 
Infectious Disease Burden: HEPATITIS A
Since the introduction of hepatitis A vaccination in 1995, cases of HAV in the U.S. have dropped 84%. 17 However, hepatitis A remains endemic in many parts of the world. High prevalence regions include sub-Saharan Africa and parts of south Asia, where it is estimated that ≥90% of the population have serologic evidence of infection by age 10. Intermediate prevalence occurs in Latin America, northern Africa, and the Middle East (≥50% with evidence of 8 infection by age 15). 18 Chronic hepatitis A has not been reported, although 10-20% of symptomatic patients experience a prolonged or relapsing course. 19 For all patients, but particularly those who have recently traveled from high-risk regions, hepatitis A should be considered in the setting of symptoms such as abdominal pain, fatigue, nausea, anorexia, urticaria and jaundice. It is important to note, however, that infected children may be asymptomatic; only about 30% of infected children exhibit symptoms (often non-specific flu-like symptoms), and viral shedding may continue in their stools for 6 months. 19 
Infectious Disease Burden: HEPATITIS B
Hepatitis B is endemic in many regions of the world as well, including much of Eastern Europe, Asia, Africa, the Middle East, and the Pacific Islands (see Figure 4) . Chronic hepatitis B infection can result in liver failure, cirrhosis, and hepatocellular carcinoma. Only 0.3-0.5% of the U.S. population is chronically infected with hepatitis B, but among foreign-born individuals, prevalence is 1.0-2.6%. 16 People who come from countries with ≥2% hepatitis B prevalence are at greatest risk for both active and chronic hepatitis B infection. These individuals should be screened via Hepatitis B surface antigen testing (HBsAg) and immunized if they are not infected (unless there is documentation that there has been prior completion of the immunization series). For foreign-born persons from high-risk countries, HBsAg testing is warranted even when there is a documented 9 history of immunization, because it is possible that infection could have occurred prior to immunization. In addition, testing is also recommended for U.S.-born persons who were not vaccinated as infants and whose parents were born in regions with ≥8% HBV endemicity (e.g., Peru, northern Brazil, Greenland, subSaharan Africa, Saudi Arabia, and much of Asia and the Pacific Islands). 16 For individuals with unknown hepatitis B immunization history, it is reasonable to consider testing for Hepatitis B surface antibody (HBsAb) before deciding to immunize; however, if the cost of serologic testing exceeds the cost of immunization, it might be more cost effective merely to vaccinate.
Infectious Disease Burden: HUMAN PAPILLOMAVIRUS
There is clear evidence in the medical literature to support the direct relationship that human papilloma virus (HPV) has on the development of cancer, including cervical, vulvar, anal, penile and oropharyngeal. HPV has been recognized as the cause of essentially all cervical cancers. [20] [21] [22] Even though the number of cervical cancer cases in the US are very low, cervical cancer affects many women worldwide. 23, 24 HPV vaccines that are available in the US and other countries have been shown to prevent the transmission of the high-risk HPV subtypes that pose the greatest risk to the development of cervical cancer. 24 For many foreign-born individuals, they are likely to be behind in cervical cancer screening. Administration of the HPV vaccine to this population at the earliest visit to the healthcare provider is essential in lowering the 
Special Considerations for Refugee Populations
According to the United Nations Convention Relating to the Status of Refugees (Article 1A: 1951), a refugee is "someone who, owing to a wellfounded fear of being persecuted for reasons of race, religion, nationality, membership of a particular social group, or political opinion, is outside the 11 country of his nationality, and is unable to or, owing to such fear, is unwilling to avail himself of the protection of that country." 25 Approximately 80,000 refugees arrive annually into the U.S., with over 2 million arrivals since 1980. 26 criteria that will be used to decide which vaccines will be required as part of the immigration process. The criteria are as follows:
(1) The vaccine must be an age-appropriate vaccine as recommended by the ACIP for the general U.S. population, and (2) At least one of the following:
a. The vaccine must protect against a disease that has the potential to cause an outbreak. b. The vaccine must protect against a disease that has been eliminated in the United States or is in the process for elimination in the United States.
Any changes made by the CDC will be reflected in the CDC's Technical
Instructions for Panel Physicians for Vaccinations.
(http://www.cdc.gov/immigrantrefugeehealth) The current requirements for routine vaccination during the immigration process are seen in Table 1 For older persons, Tdap should be administered as appropriate based on standard guidelines. 8 
Summary
Despite the great progress that has been made in the U.S. in the last century with vaccine-preventable diseases, significant morbidity and mortality is seen throughout the world in individuals who have not been vaccinated. As the foreign-born population in the U.S. continues to rise, primary care physicians must feel comfortable treating these individuals in a culturally and linguisticallyappropriate manner. 
